Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 6, 2003, Pages 703-704

  Dawar, Meenakshi ^a   Patrick, David M ^b   Bigham, Mark ^b   Cook, Darrel ^b   Krajden, Mel ^b   Ng, Helen ^b  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEPATITIS B VACCINE; MEMBRANE ANTIGEN;

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; GEOMETRY; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; LABORATORY TEST; MAJOR CLINICAL STUDY; RUBELLA; SAMPLING; SEROLOGY; SEROPREVALENCE; VACCINATION;

EID: 0037453036     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Van Damme P. Hepatitis B. Vaccination programmes in Europe - an update. Vaccine 2001;19:2375-9.
2. Huang K, Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine 2000;18(Suppl 1):S35-8.
3. Chang MH, Chen DS. Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 1999;13:511-7.
4. Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA 1995;274: 1242-3.
5. Population by sex and age. Available: www.statcan.ca/english/pgdb/people/population/demo10a.htm (accessed 2000 Apr 4).
6. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 1999;122:33-8.
7. Sweet LE, Brown MG, Lee SH, Liston RM, MacDonald MA, Forward KR. Hepatitis B prenatal screening survey, Nova Scotia, 1990-1991. Can J Public Health 1993;84:279-82.
8. Morris BA, Sabetti L. Prenatal screening for hepatitis B surface antigen. Is universal screening necessary? Can Fam Physician 1993;39:61-4.